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Abstract
Background: Patient empowerment is a key element to improve the results in health, increase satisfaction amongst
users and obtain higher treatment compliance. The main objective of this study is to validate the Spanish version of the
questionnaire “Patient empowerment in long-term conditions” which evaluates the patients’ level of empowerment of
chronic diseases. The secondary objective is to identify factors which predict basal empowerment and changes
(improvement or deterioration) in patients with Heart Failure (HF).
Methods: An observational and prospective design of psychometric type to validate a questionnaire (aim 1)
and a prospective study of cohorts (aim 2). The study will include 121 patients with confirmed diagnosis of
HF. Three measurements (basal, at 15 days and at 3 months) will be carried out: quality of life, self-care and
empowerment. Descriptive and inferential analyses will be used. For the first aim of the study (validation), the
test-retest reproducibility will be assessed through intraclass correlation coefficient; internal consistency will be
assessed through Cronbach’s alpha coefficient; construct validity through Pearson’s correlation coefficient; and
sensibility to change through effect size coefficient.
Discussion: Set a valid questionnaire to measure the level of empowerment of patients with chronic diseases could
be an effective tool to assess the results from the provision of the health care services. It will also allow us to identify at
an early stage, those groups of patients with a low level of empowerment. Hence, they could become a risk group due
to poor management of the disease, with a high rate of decompensation and a higher use rate of the health system
resources.
Keywords: Patient participation, Self-efficacy, Decision making, Personal autonomy, Quality of life, Chronic heart failure,
Metric properties, Questionnaires, Patient-reported outcomes, Nursing
Background
Ageing population is the most important phenomenon
of the last decades, with serious repercussions at a social
and economic level. In 2009, 11% of the population was
over the age of 60, it is calculated that this will increase
to 22% of the population in 2050. The population over
the age of 80 will see a higher growth rate [1]. The
ageing in the population implies a greater prevalence in
chronic diseases. In turn, the increase in chronic
diseases, comorbidity and functional dependency will
generate a high cost not only to the health system but
also at a social, economic, and human level. Since, it will
hinder individuals and communities to develop all their
potential [2].
Every country has made an effort to design and imple-
ment strategies to manage more efficiently care to
patients with chronic diseases with the objective of im-
proving their quality of life and reducing the rate of
health complications. Therefore, the health system has
had to change its focus, centred on the most acute
patients and cures, and adopt a more interdisciplinary
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vision; in which the system is patient centred. A model
whose objective is to empower patients and enable self-
management in the processes of the disease [3, 4].
The concept of empowerment is used in a great range
of contexts. One of the first contexts we have reference
of its use was found in Paulo Freire’s liberating educa-
tion philosophy [5], he uses this concept as an answer to
oppression and social inequality. Later the term was
analyzed in community physiology, critic social theory,
gender studies, rural economy studies, and finally, in
health education and promotion [6–8].
In the health field, the term in its use, has also got a
long history. Firstly, it was adopted as the key element
to promote health, later it was used as a way to increase
autonomy and the participation of the patients in
decision making related to their health. Finally, with the
increase of chronic pathologies, it is the strategy used so
patients participate and take responsibility of their own
care with the aim of improving their results in health
and secondly, to control health costs [9–11].
Although a spread consensus over the importance of
the term and its multidimensional character, there is not
a unique definition for the concept or for the different
dimensions it takes into account:
 Angelmar and Berman [10] use the proposed
definition by the World Health Organization
(WHO) for patient empowerment: a process
through which people gain greater control over
decisions and actions affecting their health. These
authors specify that the necessary conditions for
patient empowerment are: patients need to
comprehend their new role (be more active,
responsible and participative); improve their
knowledge on their health and the different
treatment options; develop abilities to carry out
self-care action in a competent manner, to improve
self-efficiency and; create a propitious environment so
professionals can facilitate two levels of the process:
motivation and health literacy.
 Varekamp [12] define it as a process to help patients
develop knowledge, abilities and gain conscience of
their needs. Simultaneously, it allows them to define
their objectives, take responsibility of their treatment
and increase their autonomy.
 Small [13] consider that empowerment is both a
process and a result derived from the communication
between professionals and patients. Through which,
information is exchanged on the resources for the
disease which increases self-control, self-efficiency, the
abilities to confront the disease and the capability of
achieving a change in their condition.
 According to Anderson [14] empowerment is also a
process and a result. The aim in the process is to
increase the capability of critical thinking and to act
autonomously, whilst the result shows self-efficiency.
From this analysis we understand that the interven-
tions of the professionals must be aimed to both the
process and the result. With regards to the process,
therapeutical relationships must be established to
encourage continuity in the relationship, centred on
the patient, to encourage decision making, incorpor-
ating abilities of confrontation and positive attitude
[15–17]. In this regard, many authors consider that
the main strategies to improve the process of
empowerment are: active listening strategy and
motivational interviews [18–20]. The nurses, due to
their competencial features, are the most prepared to
promote and facilitate support to self-care and
accompany the patient in their process of empower-
ment [21–23].
Small [24] carried out a systematic revision of
empowerment tool and assessed nine in relation to
the following criteria: definition of empowerment,
process of development of the scale, format, dimen-
sions, content of the items and punctuation and
psychometric properties of the tool.
The analysed instruments are:
 Patient Enablement Instrument (PEI) [25]
 Empowerment Scale (ES) [26, 27]
 Psychological Empowerment Questionnaire (PEQ) [28]
 Diabetes Empowerment Scale (DES) [14, 29]
 Patient Empowerment Scale (PES1) [30]
 Empirical Empowerment Measure (EMP) [31]
 Patient Empowerment Scale (PES2) [9]
 Client Empowerment Scale (CES) [32]
 Pregnancy Related Empowerment Scale (PRES) [33]
From this analysis carried out, we notice that only
three of the instruments (PEI, ES and DES) present
positive psychometric properties. Furthermore, they
have all been developed in well defined contexts and
populations: Primary care (PEI), mental health (ES,
EMP), oncology (PEQ, PRES2), as a result measure
in the design of specific educational interventions
(DES, CES, PRES), or as a measure of empowerment
of the setting (PES1).
Small [13] propose another tool to measure empower-
ment in chronic patients from a primary care perspec-
tive, based on a qualitative analysis of the concept of
empowering from the view of patients with chronic
diseases.
The tool is based on a model of empowerment
centred on the patient that includes 5 dimensions. It
contains 51 items with answers in Likert scale type of
5 points (1: completely disagree - 5: completely
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agree). After the psychometric analysis the tool is
reduced to 3 dimensions and 47 items.
1. Positive attitude and sense of control (21 items):
changes the patients experiment with regards to
self-perception after diagnosis, how they reduce the
impact of the disease in their lives and as a result
gain greater self-control (proposal for translation of
dimension: self-control or self-management).
2. Knowledge and confidence in decision making
(13 items): acquire knowledge and capability to
make decisions relative to disease management,
to be able to participate in the process of making
decisions along with the professionals and the
possibility to change their preferences (proposal of
translation of the dimension: shared decision making).
3. A mixture of dimensions in the 3rd factor: enabling
others, knowledge and understanding and decision
making, this dimension was not named (13 items).
In our country there are no validated tools which
allow to measure the combination of knowledge,
attitudes and abilities that enable the patient higher self-
control and self-efficiency in their disease management.
This lack of tools contrasts firstly, with the requests by
the Health Programs from some autonomous communi-
ties [4] of searching and implementing strategies that
allow empowerment in chronic patients. Secondly, the
WHO has claimed the need for tools to measure the
results of empowerment and for these tools to use re-
sults provided by the patients (PROMs, Patient-Reported
Outcomes Measures) [6].
Consequently, due to the lack of validated tools in
Spanish, the present study was designed with the object-
ive of carrying out the transcultural adaptation and
validation of a questionnaire which allows to explore the
level of empowerment of patients with chronic disease.
Simultaneously, it would allow to measure the effects of
the interventions designed to increase the level of
empowerment.
This study’s main aim is to validate the Spanish
version of the questionnaire “Patient empowerment in
long-term conditions” which assesses the degree of
empowerment in the management of chronic diseases.
Therefore, the following will be carried out: a) trans-
cultural adaptation of the questionnaire and b) assess-
ment of the psychometric properties (reliability through
reproducibility and internal consistency, validity of con-
struct through convergent and divergent validity by
means of comparison with other tools, questionnaire’s
sensibility to change and feasibility through description
of the answer from items as well as range, minimums
and maximums scores obtained by the items and dimen-
sions). The second objective of the study consists in
identifying patients’ empowerment patterns with heart
failure to a) identify patients’ predicting factors of basal
empowerment in relation with sociodemographic, clin-
ical and psychosocial data, b) identify predicting factors
of change (improvement or deterioration) of the degree
of empowerment with regards to the basal level, in rela-
tion with sociodemographic, clinical and psychosocial
data, c) analyzing the relation between the level of
empowerment with the incidence of hospital events,
mortality and health costs.
Methods/design
Study design
For the first aim a quantitative, longitudinal and
prospective study of pshycometric type will be carried
out to validate the questionnaire. For the second aim a
prospective study of cohorts will be performed.
The aim of the transcultural adaptation process of the
questionnaire “Patient empowerment in long-term
conditions” is that the tool is equivalent at a semantic,
conceptual and content level [34, 35] to the original
version.
Through semantic equivalence we wish to obtain the
same meaning in each one of the items, conceptual
equivalence ensures that the questionnaire measures the
same theoretical construct in both cultures and the con-
tent equivalent demonstrates that each item has the
same relevance in both cultures.
There are different methods to adapt the tools which
include direct translation, back translation, committee
assessment and pilot studies [36–38].
For this procedure the EMPRO (Evaluating the
Measurement ofPatient-Reported Outcomes) guide-
lines will be followed [39], based on the proposal of
the Medical Outcomes Trust scientific committee
(Fig. 1): a) contact with the author to request the use
permit for the tool, b) translation of the items and
the options of response in two independent versions
(bilingual translators whose mother tongue is the
same as the target population’s, who know the con-
tent and the aim of the questionnaire), c) conciliation
and synthesis of the versions in an agreed version by
the committee of experts, d) carry out the 1st pre-
final version, e) administration test of the adapted
pre-final version as sample of convenience (10–12
patients), f ) assessment of comprehension and applic-
ability of the adapted pre-final version, g) analysis of
the results by a committee of experts and design of
the 2nd pre-final version, h) inverse translation of the
2nd version to the original language by a bilingual
translator, i) agreement on the back translated version
with the author of the original version, j) create the
final version with the author’s contribution.
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Study setting
A multicenter study, which will be carried out in 3 inte-
gral health areas in the urban context of Barcelona city
and metropolitan area. Recruiting context is constituted
by the care programs for patients with HF which exist in
these health areas of the PIIC (Intervention program for
an individual and collective health care in Catalonia).
These programs include hospital units of Heart Failure
and Primary Care of the corresponding territory, they
provide a centred structured follow-up in nursery and
the participation of multidisciplinary teams (Fig. 2,
Table 1) [40, 41].
Participants
All patients with confirmed diagnosis of Heart Failure
(HF) according to the criteria of the European Cardi-
ology Society [42].
Inclusion criteria: a) patients who are admitted in
hospital with main diagnosis of HF at basal or redeter-
iorating who will carry out a follow-up at discharge in
the different care areas of PIIC, b) patients who are
willing to sign their informed consent.
Exclusion criteria: a) patients with acute coronary
syndrome, b) patients with valvular heart disease caused
by surgery to correct secondary Heart Failure in a period
inferior to 3 months, c) patients who are not able to
participate in the study due to the clinical situation or
cognitive alterations, d) language barrier which hinders
the duly completion of the questionnaire, e) patients
under 18.
Sample size
The number of individuals who must participate for the
validation of the questionnaire must be between 2 and
10 times the number of items the instrument has.
Hence, to carry out the pilot test 97 participants will be
included [43]. Estimating the possibility of a 20% of loss,
the number of individuals that need to be included in
the study are 121.
To calculate the size of the sample with regards to the
2nd objective, the level of self-care of our population is
taken as reference. Patients with a positive level of self-
care would present an average score of 197 points
(standard deviation of 80 points) in the empowerment
test. While the patients with higher scores in the self-
care test (which indicate poorer self-care) will present an
average score of 165 points (standard deviation of 60
points). Being the proportion of 1:5 between the patients
of the two groups, to demonstrate significant differences
in the empowerment test between these two with an
error of β = 0,20 y un error α = 0,05, 55 patients are
required in the group with a positive level of self-care
and 275 patients in the other, in total 330 patients with
a complete assessment of the tools at basal.
For inclusion a consecutive non-probability sampling
will be carried out.
Study measures
The variables obtained from each participant will be:
 Sociodemographic information: age, gender, marital
status, education, home sharing, presence of a carer.
 Clinical information: etiology of HF, functional class
according to the New York Heart Association
(NYHA), left ventricular ejection fraction (LVEF),
severity of the symptoms, comorbidities through
Charlson’s comorbidity index [44], years/months
passed since diagnosis, pharmacological treatment.
 Psychosocial analysis: Hospital Anxiety and
Depression Scale (HADS) [45]
 Quality of life scale: Minnesota Living With Heart
Failure questionnaire (MLWHF) [46]. A self-
administered Health Related Quality of Life tool,
specific for HF composed of 23 items and 7
dimensions: physical limitation, symptoms (stability,
frequency and severity), self-care, quality of life and
social limitation. The answer options of the items are
Likert type scales of 5, 6 and 7 points (1–5, 1–6 and
1–7), the score in each one of the dimensions has a
theoretical range that goes from 0 to 100, 100 being
the best health condition. The mentioned domains
have various questions: the domain on physical
limitation has 1 question broken down into 6 items.
With regards to frequency, the domain that includes
the symptoms comprises questions 3, 5, 7 and 9.
Original
questionnaire
Independent 
version 2
Independent
version 1
Group of experts                                          
1st pre-final version
Expert groupsAdministration test in 
target population
Back translation
2nd pre-final version 
Oiginal comparisson
Final version
Fig. 1 Cultural adaptation process of the questionnaire
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Fig. 2 Barcelona Litoral Mar transitional care model for heart failure
Table 1 Contents of the educational program
Admission Follow-up at discharge
Educational material Individual educational sessions Individual sessions
(in-person, over the phone, virtual)
Guide for patients with HF Heart failure and symptoms Session 1 (2nd week) : Assess self-care, explain signs
of alarm and flexible diet of diuretics
Diet: salt and liquids
Table of exercises Weight control (meaning of sudden increase
in weight)
Session 2 (4th week): reinforce information on diet
habits (salt and liquids) and healthy habits
Notebook for weight control Signs of alarm: identify signs of decompensation
and prevent situations of risk
Session 3 (6th week) pharmacological treatment
Control of liquids intake Pharmacological treatment: Effects, Doses and
time of administration, Secondary effects, signs
of intoxication or intolerance, Self-management
of diuretics or Antihypertensive.
Session 4 (8th week): Assessment of knowledge on
alarm signs, flexible diet of diuretics, diet (salt and
liquids), healthy habits and medication
Promote giving up toxic habits
Exercise and rest
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Severity in questions 4, 6 and 8 and stability or change
in time in question 2. The domain that collects the
information on self-care includes questions 10 and 11,
and the domain that inquires on quality of life includes
questions 12–14.While the domain on social
limitation includes question 15 which contains 4 items.
 Self-care level: European Heart Failure Self-care
Behaviour Scale (EHFScBS) [47]. This scale consists
of an administrated questionnaire with 12 items
which deal with different aspects of patients’ self-care.
Each item is scored from 1 (I completely agree/
always) to 5 (I completely disagree/never). The
global score may vary, from 12 (better self-care)
to 60 (worse self-care).
 Self-efficiency level: General Self-efficiency Scale [48].
Assesses stability feeling of personal competence to
manage efficiently a great variety of stressful
situations. The only change made in the original
questionnaire, which consists of 10 items with Likert
type scales of 4 points, was the format of answer to
scales of 10 points.
 Level of empowerment: Patient empowerment in
long-term conditions [13]
Procedure and data collection
An initial interview and two follow-up interviews at
week 2 and 12 after inclusion (Fig. 3).
Initial interview: with the coordinator nurse of HF in
the hospital unit, the first working day after hospitalization
and before the educational program. At this point the
sociodemographic and clinical variables will be collected
as well as the basal questionnaires. The questionnaires
Patient empowerment, MLWHF, HADS, EHFScBS and
Self-efficiency are handed out. The questionnaires will be
collected between 24 and 48 h after their delivery. The
data collected from the tools will allow to assess the
internal consistency of the questionnaire, its validity,
sensibility (pre-intervention) and feasibility.
2nd interview: carried out at 2 weeks from the initial
interview. The information collection will be carried out
by the nurses responsible for each care field of the
program. The Patient empowerment questionnaire will
be handed out and will be collected before the interview
ends. The data collected will allow to analyse reproduci-
bility (re-test).
3rd interview: carried out at 3 months from the 2nd
interview. The context, people in charge, and methods
of data collection will be the same as in interview 2.
Clinical information will be gathered to assess, improve-
ment or worsening of the patient. Patient empowerment,
MLWHF and EHFScBS questionnaires will be handed
out. The data gathered on tools will allow to assess
sensibility (post-intervention).
Data analysis
A descriptive analysis will be carried out of the features
of the total sample and of the sub-samples “stability”
and “improvement”. The qualitative variables will be
analysed through the description of frequencies of each
one of the categories whilst, the quantitative variables
will be described with the average, median and typical
deviation.
The psychometric analysis of the tool will be carried
out by means of reliability, construct validity, sensibility
towards change and feasibility.
Feasibility being the property of a questionnaire to
distinguish up to what point a variable fluctuates as the
result of an error in the measurement or a real change,
in other words, the degree an instrument is free from
aleatory error. The criteria used to measure feasibility
are internal consistency and reproducibility or stability.
To evaluate internal consistency Cronbach’s alfa coeffi-
cient (initial evaluation) will be used as indicator and
reproducibility test-retest by means of the intraclass cor-
relation coefficient [35, 46, 49] from the data gathered
during the 1st and 2nd interviews.
The construct validity analyses the degree of correl-
ation of the questionnaire with other tests that measure
equal or similar aspects (convergent validity) or different
ones (divergent validity). For this matter, a matrix of
Day O
Admission
Day 1 
1st interview
Sociodemographic 
and clinical variabes 
Questionnaires: 
Patient 
empowerment, 
MLWHF, HADS, 
Self-care and Self-
efficiency
Week 2
2nd interview
Clinical variables
Questionnaires: 
Patient 
empowerment,
Week 12 
3rd interview
Clinical variables, 
mortality, readmission in 
hospital.
Questionnaires:
Patient empowerment, 
MLWHF, Self-care. 
Fig. 3 Data collection method
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correlations of the dimensions of Patient empowerment
in long-term conditions/General Self-Efficacy Scale/
MLWHF/EHFScBS will be designed. Pearson’s correl-
ation coefficient is used in means of statistics (data from
the 1st interview) [35, 39, 46].
Sensibility to change is evaluated through the size of
the effect that relates the average (Wilcoxon test) of the
differences amongst the scores before (1st interview)
and after intervention (3rd interview) [35, 46, 49].
For each questionnaire is evaluated the range of scores
observed, the percentage of patients with an unanswered
item in each domain (as a measure of feasibility) and the
percentage of patients with either a maximum score (as a
measure of the ceiling effect) or a minimum score (as a
measure of the floor effect) [46, 49].
To describe changes in the sample through time the
Student t-test will be used, for paired samples, the pres-
ence of unique empowerment trajectories will be
explored using models of “growth mixture modelling”
type (GMM) [50, 51].
Statistics meaning is established at equivalence 5%
(p < 0,05). Data will be analysed with software Statis-
tical Analysis System (SAS) 9.4.
Validity and reliability
All the questionnaires used in this study have been
validated in the Spanish context except for the question-
naire proposed in this study. These questionnaires will
be used during a structured follow-up of the patients
with HF. Therefore, nurses will be trained in their use
and the three Units of HF that participate share the
same procedures and clinical practise.
There will be a coordinator in each hospital who will
validate the data obtained to ensure quality, and an
expert coordinator who will organise the hospitals
included in the study and the data collection.
Discussion
Empowerment is a multidimensional concept that offers
information on the ability of self-care and self-
management of the disease but, it also gathers psycho-
social aspects which are decisive in the perception of
quality of life. Therefore, it is necessary to carry out the
validation of the tool that measures this concept. A tool
that we lack, and will offer us the results that we could
only gather previously with different tools, and that
often did not provide the information on all the dimen-
sions needed.. Moreover, this tool goes hand in hand
with the objective of patient centred healthcare, for
which both patients and professionals must understand
their new role, patients who are more active and profes-
sionals who act as facilitators of this process, to promote
a relation of association, to help patients be more active
by transferring knowledge and abilities. This implies the
need of modifying the pillars of health education since it
is not only about transferring knowledge but also of
achieving a change in behaviour and developing strat-
egies of confrontation. Therefore, professionals must
incorporate in their practice communicative knowledge
and abilities that allow changing the paradigm.
This project also suggests the need of creating and
fomenting synergies between the different levels of
health care, putting the patient in the focus rather than
the health structures.
Limitations
The main limitation of the study lies in the features of
the validation process of the original tool with regards to
the metric properties. Since in the original version, the
internal consistency of the questionnaire and the validity
of the construct were evaluated but the reproducibility
and sensibility to change were not [13]. With regards to
the disease, the original questionnaire was validated in a
chronic heterogeneous patient population (diabetes,
asthma and ischemic heart disease). Whilst in this study
it has been decided to carry out validation through
patients with HF, in later studies chronic patients with
diverse pathologies need to be included.
Regarding the identification of the patterns and trajec-
tories of empowerment, this study has a cohort of
3 months follow-up, taking into account that during this
period the patients receive educational intervention, it
would be interesting to carry out a follow-up of the
cohort during a longer period of time.
On the other hand, it is an observational study that
intends to quantify the associations produced between
empowerment and clinical, sociodemographic and
psychosocial data. Therefore, it will be necessary to
design future experimental studies that provide
additional information between the improvement in
modifiable factors and the level of empowerment.
Conclusion
By setting a scale that indicates the degree of empower-
ment, we will be able to identify those groups of patients
with a low empowerment level at an early stage which
could consequently, become a risk group due to poor
management of the disease, with a high rate of decom-
pensation and higher use of health resources. Will allow
us to act in a preventive way, through specific educa-
tional programs which include innovative methods of
communication in those patients with profiles that show
a low empowerment pattern, or an unfavourable
empowerment change. It will also be a tool which will
allow us to measure the effects of the designed interven-
tions to increase the level of empowerment.
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